Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 146,836 shares at $70.04 ($10.3M) on 2018-11-01, disclosed to the SEC on 2018-11-05.
Open-market sale of $10.3M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.04 | 19,677 | $1.4M | 13.4% |
| 2 | $70.04 | 19,677 | $1.4M | 13.4% |
| 3 | $70.26 | 53,741 | $3.8M | 36.6% |
| 4 | $70.26 | 53,741 | $3.8M | 36.6% |
| Total | $70.20 avg | 146,836 | $10.3M | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |